Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
aldehyde
aldeyra therapeutics
allergic conjunctivitis
ally bridge group
big data analytics
biotech
blackrock
casdin capital
diabetic nephropathy
drugs
dry eye disease
eventide asset management
focal segmental glomerulosclerosis
goldfinch bio
irving investors
jay ghosh
national top stories
reproxalab
schroeder adveq
sjogren-larsson syndrome
software
third rock ventures
wellington management company
yonjin capital
What
drug
new
studies
2
×
aldeyra
analysis
bio
biotech
bring
closer
company
data
develop
disclosed
diseases
employing
eye
fda
fighting
filing
genetic
goldfinch
inflammation
ipo
kidney
later
lead
medicine
medicines
million
multiple
phase
positive
puts
raised
raises
results
step
therapeutics
type
Language
unset
Current search:
studies
×
boston
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
